Your browser doesn't support javascript.
loading
Laparoscopic cryotherapy for small renal masses: Current State.
Cordeiro, E R; Barwari, K; Anastasiadis, A; García, M; Branco, F; de la Rosette, J J; Laguna, M P.
Afiliação
  • Cordeiro ER; Servicio de Urologúa, Hospital AMC, Amsterdam, Holanda. ercordeiro@hotmail.com
Arch Esp Urol ; 66(1): 41-53, 2013.
Article em En, Es | MEDLINE | ID: mdl-23406799
OBJECTIVES: To provide an up-to-date review of the available literature on laparoscopic cryotherapy for small renal masses (SRMs) including technique description, indications and outcomes. METHODS: A systematic literature search was conducted in March 2012, using MEDLINE and EMBASE via Ovid databases, to identify studies on laparoscopic cryotherapy for SRMs published during the last 10 years. Only English-language and human-based full manuscripts reporting case series studies with >20 participants, patient characteristics, efficacy and safety data were included. RESULTS: No randomised controlled trials (RCTs)were identified. In total, 27 full reports addressing laparoscopic cryoablation (LCA) for SRMs were selected. The number of patients per study ranged from 20 to 144. Mean age of treated patients across the series ranged from 62 to 73 years. Mean size of renal tumors ranged from 2.7 to 4 cm, being in most cases <3 cm. The number of cryoprobes used for cryoablation ranged from 1 to 6, and only 10 series described the use of 17-gauge (1.47 mm) third-generation needles. Overall, more than 55% of all ablated lesions were pathologically confirmed RCC. Mean follow-up ranged from 9 to 93 months. Only 7 series presented a long-term follow-up of more than 36 months. Most studies were limited by a relatively short follow-up. At least four urologic groups reported intermediate- and long-term outcomes. Persistence rates ranged from 0% to 17% and recurrence rates ranged from 0% to 14%. Overall complication rates ranged from 0% to 40%. CONCLUSIONS: Retrospective observational data and a few prospective series on LCA of SRMs show acceptable oncological 3- to 5-year outcomes with a low recurrence rate. It has proven to be a safe procedure with an overall low complication rate. It is mainly indicated for SRMs in elderly patients affected by co-morbidity and high surgical risk bearing tumours in the anterior valve of the kidney or in contact with the ureter or neighbouring organs.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Laparoscopia / Crioterapia / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Arch Esp Urol Ano de publicação: 2013 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Laparoscopia / Crioterapia / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Arch Esp Urol Ano de publicação: 2013 Tipo de documento: Article